Less Ads, More Data, More Tools Register for FREE

Pin to quick picksERGO.L Regulatory News (ERGO)

  • There is currently no data for ERGO

Block Listing Six Monthly Return

2 Jan 2019 07:00

RNS Number : 7694L
Ergomed plc
02 January 2019
 

BLOCK LISTING SIX MONTHLY RETURN

 

 

Date: 2 January 2019

 

Name of applicant:

Ergomed plc

Name of scheme:

Ergomed plc Long Term Incentive Plan

Period of return:

From:

2 July 2018

To:

31 December 2018

Balance of unallotted securities under scheme(s) from previous return:

1,800,000 (original admission)

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

nil

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

55,000

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

1,745,000

Number and class of securities originally admitted and the date of admission

1,800,000 ordinary shares of 1p each - 2 July 2018

Total number of securities in issue at the end of the period

45,016,438 ordinary shares of 1p each

 

Name of contact:

Nick Blech - Deputy CFO

Telephone number of contact:

+44 (0)7768 547372

 

 Enquiries:

Ergomed plc

Tel: +44 (0) 1483 503205

Stephen Stamp (Chief Executive Officer)

Stuart Jackson (Chief Financial Officer)

 

Numis Securities Limited

Tel: +44 (0) 20 7260 1000

Michael Meade / Freddie Barnfield (Nominated Adviser)

James Black (Broker)

 

Consilium Strategic Communications - for UK enquiries

Tel: +44 (0) 20 3709 5700

Chris Gardner / Mary-Jane Elliott

Matthew Neal / Olivia Manser

 

ergomed@consilium-comms.com

MC-Services - for Continental European enquiries

Tel: +49 211 5292 5222

Anne Hennecke

 

About Ergomed plc

Ergomed provides specialist services to the pharmaceutical industry spanning all phases of clinical development, post-approval pharmacovigilance and medical information. Ergomed's fast-growing, profitable services offering encompasses a complete suite of specialist pharmacovigilance solutions, integrated under the PrimeVigilance brand, in addition to a full range of high quality contract research and trial management services (CRO). Leveraging its CRO expertise, Ergomed also has a drug development portfolio of co-development partnerships and wholly-owned programmes. For further information, visit: http://ergomedplc.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BLRFEWFWAFASEEE
Date   Source Headline
14th Nov 20237:00 amRNSCancellation - Ergomed plc
13th Nov 20233:30 pmRNSForm 8.3 - ERGO LN
13th Nov 20233:20 pmRNSForm 8.3 - Ergomed plc
13th Nov 202312:00 pmRNSForm 8.5 (EPT/RI) - Ergomed Plc
13th Nov 202310:37 amRNSScheme of Arrangement becomes Effective
13th Nov 202310:24 amRNSForm 8.5 (EPT/RI) - Ergomed Plc
13th Nov 20237:30 amRNSSuspension - Ergomed plc
10th Nov 20233:47 pmRNSHolding(s) in Company
10th Nov 20233:30 pmRNSForm 8.3 - ERGO LN
10th Nov 20233:30 pmGNWForm 8.3 - Ergomed plc
10th Nov 20233:29 pmRNSForm 8.3 - Ergomed plc
10th Nov 20233:20 pmRNSForm 8.3 - Ergomed plc
10th Nov 20233:15 pmPRNForm 8.3 - Ergomed Plc
10th Nov 20233:05 pmRNSHolding(s) in Company
10th Nov 202312:05 pmGNWForm 8.3 - Ergomed PLC
10th Nov 202312:00 pmRNSForm 8.5 (EPT/RI) - Ergomed Plc
10th Nov 202310:50 amGNWMan Group PLC : Form 8.3 - Ergomed plc
10th Nov 202310:45 amRNSForm 8.3 - Ergomed plc
9th Nov 20233:30 pmGNWForm 8.3 - Ergomed plc
9th Nov 20233:20 pmRNSForm 8.3 - Ergomed plc
9th Nov 20232:27 pmRNSIssue of Equity and Rule 2.9 Announcement
9th Nov 20232:16 pmRNSCourt Sanction of the Scheme of Arrangement
9th Nov 202312:00 pmRNSForm 8.5 (EPT/RI) - Ergomed Plc
8th Nov 20236:00 pmRNSErgomed
8th Nov 20233:20 pmRNSForm 8.3 - Ergomed plc
8th Nov 202312:00 pmRNSForm 8.5 (EPT/RI) - Ergomed Plc
8th Nov 20238:12 amRNSForm 8.5 (EPT/NON-RI) Ergomed Plc
7th Nov 202312:00 pmRNSForm 8.5 (EPT/RI) - Ergomed Plc
6th Nov 20233:30 pmGNWForm 8.3 - Ergomed plc
6th Nov 20233:20 pmRNSForm 8.3 - Ergomed plc
6th Nov 20232:04 pmGNWForm 8.3 - Ergomed Plc
6th Nov 202312:00 pmRNSForm 8.5 (EPT/RI) - Ergomed Plc
6th Nov 202311:50 amRNSForm 8.3 - Ergomed plc
6th Nov 20238:34 amRNSForm 8.5 (EPT/NON-RI) Ergomed Plc
3rd Nov 20233:30 pmGNWForm 8.3 - Ergomed plc
3rd Nov 202312:00 pmRNSForm 8.5 (EPT/RI) - Ergomed Plc
3rd Nov 20239:33 amGNWMan Group PLC : Form 8.3 - Ergomed plc
2nd Nov 20233:30 pmGNWForm 8.3 - Ergomed plc
2nd Nov 20233:21 pmRNSStatement re Publication of Finance Documentation
2nd Nov 202312:48 pmGNWForm 8.3 - Ergomed Plc
2nd Nov 202312:00 pmRNSForm 8.5 (EPT/RI) - Ergomed Plc
2nd Nov 202311:45 amRNSForm 8.3 - Ergomed plc
2nd Nov 20237:59 amRNSForm 8.5 (EPT/NON-RI) Ergomed Plc
1st Nov 20233:20 pmRNSForm 8.3 - Ergomed plc
1st Nov 202312:00 pmRNSForm 8.5 (EPT/RI) - Ergomed Plc
1st Nov 202312:00 pmRNSForm 8.5 (EPT/RI) - Ergomed Plc
1st Nov 202311:25 amRNSForm 8.3 - Ergomed plc
1st Nov 20238:50 amRNSForm 8.5 (EPT/NON-RI) Ergomed Plc
1st Nov 20237:00 amRNSIssue of Equity and Rule 2.9 Announcement
31st Oct 20235:09 pmGNWForm 8.3 - Ergomed plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.